93 related articles for article (PubMed ID: 744093)
1. Prolactin suppression by (-) delta-9-tetrahydrocannabinol (THC): involvement of serotonergic and dopaminergic pathways.
Kramer J; Ben-David M
Endocrinology; 1978 Aug; 103(2):452-7. PubMed ID: 744093
[TBL] [Abstract][Full Text] [Related]
2. Prolactin response to electroconvulsive shock in anesthetized rats.
Golan D; Aharoni A; Halbreich U
J Psychiatr Res; 1993; 27(3):235-40. PubMed ID: 8295155
[TBL] [Abstract][Full Text] [Related]
3. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
Krulich L; McCann SM; Mayfield MA
Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
[TBL] [Abstract][Full Text] [Related]
4. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
[TBL] [Abstract][Full Text] [Related]
5. Delta 9-tetrahydrocannabinol suppression of prolactin secretion in the rat: lack of direct pituitary effect.
Hughes CL; Everett JW; Tyrey L
Endocrinology; 1981 Sep; 109(3):876-80. PubMed ID: 6266813
[TBL] [Abstract][Full Text] [Related]
6. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
[TBL] [Abstract][Full Text] [Related]
7. Effect of serotonergic drugs on the aggressiveness induced by delta 9-tetrahydrocannabinol in rem-sleep-deprived rats.
Carlini EA; Lindsey CJ
Braz J Med Biol Res; 1982 Oct; 15(4-5):281-3. PubMed ID: 6303479
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.
Rodríguez De Fonseca F; Fernández-Ruiz JJ; Murphy LL; Cebeira M; Steger RW; Bartke A; Ramos JA
Pharmacol Biochem Behav; 1992 Jun; 42(2):269-75. PubMed ID: 1321451
[TBL] [Abstract][Full Text] [Related]
9. The effect of TRH, cyproheptadine and pimozide on the growth hormone response to intramuscular glucagon.
Hainer V; Urbánek J; Malec B; Krejcik L
Horm Metab Res; 1981 Aug; 13(8):451-3. PubMed ID: 6799379
[TBL] [Abstract][Full Text] [Related]
10. Possible dopaminergic system involvement in LH and PRL responses to naltrexone treatment.
Yogev L; Gottreich A; Homonnai ZT; Paz GF
Life Sci; 1989; 45(24):2343-9. PubMed ID: 2601582
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evidence of an interaction between serotonergic and dopaminergic neurons in the control of prolactin secretion in male rats.
Quattrone A; Schettini G; Di Renzo GF; Preziosi P
Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):42-9. PubMed ID: 485703
[TBL] [Abstract][Full Text] [Related]
12. The interaction of dopaminergic and serotonergic drugs on plasma prolactin in ovariectomized, estrogen-treated rats.
Lawson DM; Gala RR
Endocrinology; 1976 Jan; 98(1):42-7. PubMed ID: 1248448
[TBL] [Abstract][Full Text] [Related]
13. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat.
Koenig J; Mayfield MA; Coppings RJ; McCann SM; Krulich L
Brain Res; 1980 Sep; 197(2):453-68. PubMed ID: 6105900
[TBL] [Abstract][Full Text] [Related]
14. Reversal of the delta-9-tetrahydrocannabinol inhibitory effect on prolactin secretion by rostral deafferentation of the medial basal hypothalamus.
Tyrey L
Neuroendocrinology; 1986; 44(2):204-10. PubMed ID: 3025759
[TBL] [Abstract][Full Text] [Related]
15. Effects of (-)-trans- delta 9-tetrahydrocannabinol on serum prolactin in the pseudopregnant rat.
Hughes CL; Tyrey L
Endocr Res Commun; 1982; 9(1):25-36. PubMed ID: 6284475
[TBL] [Abstract][Full Text] [Related]
16. Naloxone blocks the effects of delta 9-tetrahydrocannabinol on serum luteinizing hormone and prolactin in rats.
Kumar MS; Simpkins JW
Subst Alcohol Actions Misuse; 1983; 4(5):347-53. PubMed ID: 6322367
[TBL] [Abstract][Full Text] [Related]
17. Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion.
Ferrari C; Caldara R; Romussi M; Rampini P; Telloli P; Zaatar S; Curtarelli G
Neuroendocrinology; 1978; 25(6):319-28. PubMed ID: 662080
[TBL] [Abstract][Full Text] [Related]
18. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
Lawson DM; Gala RR
Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
[TBL] [Abstract][Full Text] [Related]
19. Acute decreases in serum prolactin concentrations caused by delta 9-tetrahydrocannabinol in nonhuman primates.
Asch RH; Smith CG; Siler-Khodr TM; Pauerstein CJ
Fertil Steril; 1979 Nov; 32(5):571-5. PubMed ID: 115723
[TBL] [Abstract][Full Text] [Related]
20. Involvement of dopamine in prolactin release induced by electrical stimulation of the hypothalamus of the female turkey (Meleagris gallopavo).
el Halawani ME; Youngren OM; Silsby JL; Phillips RE
Gen Comp Endocrinol; 1991 Dec; 84(3):360-4. PubMed ID: 1808016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
